Volume 19, Number 10—October 2013
Dispatch
Primary Multidrug-Resistant Mycobacterium tuberculosis in 2 Regions, Eastern Siberia, Russian Federation
Table 1
MIRU-VNTR 12 | Family/ MIT | Irkutsk |
p value | Yakutia |
p value | |||
---|---|---|---|---|---|---|---|---|
No. (%) total, n = 105 | No. (%) MDR, n = 25 | No. (%) total, n = 130 | No. (%) MDR, n = 36 | |||||
223325153533 | Beijing 16 | 32 (31) | 7 (28) | <0.001 | 12 (9) | 1 (3) | 0.006 | |
223325173533 | Beijing 17 | 13 (12) | 6 (24) | 0.27 | 10 (8) | 7 (19) | 0.76 | |
233325153325 | S 256 | 0 | 0 | <0.001 | 14 (11) | 12 (33) | 0.001 | |
223125153324 | T 8 | 0 | 0 | NA | 9 (7) | 0 | 0.005 | |
227225113223 | Ural 171 | 0 | 0 | NA | 6 (5) | 0 | 0.03 | |
223325153433 | Beijing 592 | 1 (1) | 0 | NA | 4 (3) | 0 | 0.38 |
*MIRU-VNTR, mycobacterial interspersed repetitive unit–variable number tandem repeat (original 12-loci profile). Included genotypes found in >5 isolates only; MIT, MIRU–VNTR international type; MDR, multidrug-resistant tuberculosis (conventional resistance to isoniazid and rifampin); NA, not applicable. Significance determined by χ2 analysis with Yates correction or Fisher exact test when appropriate.
1These authors contributed equally to this article.
Page created: September 16, 2013
Page updated: September 16, 2013
Page reviewed: September 16, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.